Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells
Open Access
- 5 January 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 9 (1), 1-6
- https://doi.org/10.1186/s13104-015-1836-y
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c MiceJournal of Virology, 2011
- Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infectionJournal of Virological Methods, 2011
- Respiratory Syncytial Virus F and G Proteins Induce Interleukin 1α, CC, and CXC Chemokine Responses by Normal Human Bronchoepithelial CellsThe Journal of Infectious Diseases, 2010
- The antimicrobial peptide LL-37 inhibits HIV-1 replication.Current HIV Research, 2007
- LL-37, the only human member of the cathelicidin family of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Culture of Calu-3 Cells at the Air Interface Provides a Representative Model of the Airway Epithelial BarrierPharmaceutical Research, 2006
- Respiratory Syncytial Virus Induces TLR3 Protein and Protein Kinase R, Leading to Increased Double-Stranded RNA Responsiveness in Airway Epithelial CellsThe Journal of Immunology, 2006
- Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine ExpressionJournal of Virology, 2005
- Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitorJournal of Antimicrobial Chemotherapy, 2005
- Human Cathelicidin (LL-37), a Multifunctional Peptide, is Expressed by Ocular Surface Epithelia and has Potent Antibacterial and Antiviral ActivityCurrent Eye Research, 2005